These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19175689)

  • 1. Oncolytic virotherapy for advanced liver tumours.
    Chang JF; Chen PJ; Sze DY; Reid T; Bartlett D; Kirn DH; Liu TC
    J Cell Mol Med; 2009 Jul; 13(7):1238-47. PubMed ID: 19175689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted genetic and viral therapy for advanced head and neck cancers.
    Huang PI; Chang JF; Kirn DH; Liu TC
    Drug Discov Today; 2009 Jun; 14(11-12):570-8. PubMed ID: 19508919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies.
    Nettelbeck DM; Leber MF; Altomonte J; Angelova A; Beil J; Berchtold S; Delic M; Eberle J; Ehrhardt A; Engeland CE; Fechner H; Geletneky K; Goepfert K; Holm PS; Kochanek S; Kreppel F; Krutzke L; Kühnel F; Lang KS; Marchini A; Moehler M; Mühlebach MD; Naumann U; Nawroth R; Nüesch J; Rommelaere J; Lauer UM; Ungerechts G
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic virotherapy in hepato-bilio-pancreatic cancer: The key to breaking the log jam?
    Li Y; Shen Y; Zhao R; Samudio I; Jia W; Bai X; Liang T
    Cancer Med; 2020 May; 9(9):2943-2959. PubMed ID: 32130786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional liver therapy using oncolytic virus to target hepatic colorectal metastases.
    Carpenter SG; Carson J; Fong Y
    Semin Oncol; 2010 Apr; 37(2):160-9. PubMed ID: 20494708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumoural immunity by virus-mediated immunogenic apoptosis inhibits metastatic growth of hepatocellular carcinoma.
    Boozari B; Mundt B; Woller N; Strüver N; Gürlevik E; Schache P; Kloos A; Knocke S; Manns MP; Wirth TC; Kubicka S; Kühnel F
    Gut; 2010 Oct; 59(10):1416-26. PubMed ID: 20675696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress.
    Liu TC; Galanis E; Kirn D
    Nat Clin Pract Oncol; 2007 Feb; 4(2):101-17. PubMed ID: 17259931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced new strategies for metastatic cancer treatment by therapeutic stem cells and oncolytic virotherapy.
    Park GT; Choi KC
    Oncotarget; 2016 Sep; 7(36):58684-58695. PubMed ID: 27494901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy.
    Zhang B; Cheng P
    Mol Cancer; 2020 Nov; 19(1):158. PubMed ID: 33172438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic viral therapy using reovirus.
    Thirukkumaran C; Morris DG
    Methods Mol Biol; 2009; 542():607-34. PubMed ID: 19565924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emergence of combinatorial strategies in the development of RNA oncolytic virus therapies.
    Nguyen TL; Tumilasci VF; Singhroy D; Arguello M; Hiscott J
    Cell Microbiol; 2009 Jun; 11(6):889-97. PubMed ID: 19388908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles to the Rescue: A Review of Oncolytic Measles Virus.
    Aref S; Bailey K; Fielding A
    Viruses; 2016 Oct; 8(10):. PubMed ID: 27782084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic virotherapy for urological cancers.
    Delwar Z; Zhang K; Rennie PS; Jia W
    Nat Rev Urol; 2016 Jun; 13(6):334-52. PubMed ID: 27215429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial.
    Park BH; Hwang T; Liu TC; Sze DY; Kim JS; Kwon HC; Oh SY; Han SY; Yoon JH; Hong SH; Moon A; Speth K; Park C; Ahn YJ; Daneshmand M; Rhee BG; Pinedo HM; Bell JC; Kirn DH
    Lancet Oncol; 2008 Jun; 9(6):533-42. PubMed ID: 18495536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poxvirus oncolytic virotherapy.
    Torres-Domínguez LE; McFadden G
    Expert Opin Biol Ther; 2019 Jun; 19(6):561-573. PubMed ID: 30919708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinase inhibitors with viral oncolysis: Unmasking pharmacoviral approaches for cancer therapy.
    Gilchrist VH; Jémus-Gonzalez E; Said A; Alain T
    Cytokine Growth Factor Rev; 2020 Dec; 56():83-93. PubMed ID: 32690442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical testing of virotherapeutics for primary and secondary tumors of the liver.
    Zimmermann M; Weiland T; Bitzer M; Lauer UM
    Methods Mol Biol; 2012; 806():121-36. PubMed ID: 22057449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models.
    Zhang J; Lai W; Li Q; Yu Y; Jin J; Guo W; Zhou X; Liu X; Wang Y
    Biochem Biophys Res Commun; 2017 Sep; 491(2):469-477. PubMed ID: 28698142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic virotherapy.
    Cervantes-García D; Ortiz-López R; Mayek-Pérez N; Rojas-Martínez A
    Ann Hepatol; 2008; 7(1):34-45. PubMed ID: 18376364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oncolytic adenoviruses in anti-cancer therapy: current status and perspectives].
    Sviatchenko VA; Tarasova MV; Netesov SV; Chumakov PM
    Mol Biol (Mosk); 2012; 46(4):556-69. PubMed ID: 23113343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.